Abstract
Cobalamin C (Cbl-C) defect is the most common inborn cobalamin metabolism error; it causes impaired conversion of dietary vitamin B12 into its two metabolically active forms, methylcobalamin and adenosylcobalamin. Cbl-C defect causes the accumulation of methylmalonic acid and homocysteine and decreased methionine synthesis. The gene responsible for the Cbl-C defect has been recently identified, and more than 40 mutations have been reported. MMACHC gene is located on chromosome 1p and catalyzes the reductive decyanation of CNCbl. Cbl-C patients present with a heterogeneous clinical picture and, based on their age at onset, can be categorized into two distinct clinical forms. Early-onset patients, presenting symptoms within the first year, show a multisystem disease with severe neurological, ocular, haematological, renal, gastrointestinal, cardiac, and pulmonary manifestations. Late-onset patients present a milder clinical phenotype with acute or slowly progressive neurological symptoms and behavioral disturbances. To improve clinical course and metabolic abnormalities, treatment of Cbl-C defect usually consists of a combined approach that utilizes vitamin B12 to increase intracellular cobalamin and to maximize deficient enzyme activities, betaine to provide a substrate for the conversion of homocysteine into methionine through betaine-homocysteine methyltransferase, and folic acid to enhance remethylation pathway. No proven efficacy has been demonstrated for carnitine and dietary protein restriction. Despite these measures, the long-term follow-up is unsatisfactory especially in patients with early onset, with frequent progression of neurological and ocular impairment. The unfavorable outcome suggests that better understanding of the pathophysiology of the disease is needed to improve treatment protocols and to develop new therapeutic approaches.
Similar content being viewed by others
Abbreviations
- AdoCbl:
-
Adenosylcobalamin
- BHMT:
-
Betaine-homocysteine methyltransferase
- Cbl:
-
Cobalamin
- CBS:
-
Cystathionine beta synthase
- HUS:
-
Hemolytic uremic syndrome
- MeCbl:
-
Methylcobalamin
- MMA:
-
Methylmalonic acid
- MTHFR:
-
Methyl tetrahydrofolate reductase
- OH-Cbl:
-
Hydroxycobalamin
- SAM:
-
S-adenosylmethionine
- SAH:
-
S-adenosylhomocysteine
References
Andersson HC, Shapira E (1998) Biochemical and clinical response to hydroxycobalamin versus cyanocobalamin treatment in patients with methylmalonic academia and homocystinuria (Cbl-C). J Pediatr 132:121–124
Andersson HC, Marble M, Shapira E (1999) Long-term outcome in treated combined methylmalonic acidemia and homocystinemia. Genet Med 1(4):146–150
Andrès E, Affenberger S, Federici L, Korganow AS (2006) Pseudo-thrombotic microangiopathy related to cobalamin deficiency. Am J Med 119(12):e3
Bartholomew DW, Batshaw ML, Allen RH et al (1988) Therapeutic approaches to cobalamin-C methylmalonic acidemia and homocystinuria. J Pediatr 112(1):32–39
Baumgartner ER, Wick H, Maurer R, Egli N, Steinmann B (1979) Congenital defect in intracellular cobalamin metabolism resulting in homocysteinuria and methylmalonic aciduria. I. Case report and histopathology. Helv Paediatr Acta 34(5):465–482
Biancheri R, Cerone R, Rossi A et al (2002) Early-onset cobalamin C/D deficiency: epilepsy and electroencephalographic features. Epilepsia 43(6):616–622
Bodamer OA, Rosenblatt DS, Appel SH, Beaudet AL (2001) Adult-onset combined methylmalonic aciduria and homocystinuria (Cbl-C). Neurology 56(8):1113
Bodamer OA, Sahoo T, Beaudet AL et al (2005) Creatine metabolism in combined methylmalonic aciduria and homocystinuria. Ann Neurol 57(4):557–560
Brandstetter Y, Weinhouse E, Splaingard ML, Tang TT (1990) Cor pulmonale as a complication of methylmalonic acidemia and homocystinuria (Cbl-C type). Am J Med Genet 36(2):167–171
Brunelli SM, Meyers KE, Guttenberg M, Kaplan P, Kaplan BS (2002) Cobalamin C deficiency complicated by an atypical glomerulopathy. Pediatr Nephrol 17(10):800–803
Butler CC, Vidal-Alaball J, Cannings-John R et al (2006) Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency: a systematic review of randomized controlled trials. Fam Pract 23(3):279–285
Carrillo-Carrasco N, Sloan J, Valle D, Hamosh A, Venditti CP (2009) Hydroxocobalamin dose escalation improves metabolic control in Cbl-C. J Inherit Metab Dis 32(6):728–731
Cerone R, Schiaffino MC, Caruso U, Lupino S, Gatti R (1999) Minor facial anomalies in combined methylmalonic aciduria and homocystinuria due to a defect in cobalamin metabolism. J Inherit Metab Dis 22(3):247–250
De Bie I, Nizard SD, Mitchell GA (2009) Fetal dilated cardiomyopathy: an unsuspected presentation of methylmalonic aciduria and hyperhomocystinuria, Cbl-C type. Prenat Diagn 29(3):266–270
Deodato F, Boenzi S, Santorelli FM, Dionisi-Vici C (2006) Methylmalonic and propionic aciduria. Am J Med Genet C Semin Med Genet 142C(2):104–112
Detich N, Hamm S, Just G, Knox JD, Szyf M (2003) The methyl donor S-adenosylmethionine inhibits active demethylation of DNA: a candidate novel mechanism for the pharmacological effects of S-adenosylmethionine. J Biol Chem 278(23):20812–20820
Di Rocco A, Bottiglieri T, Werner P et al (2002) Abnormal cobalamin-dependent transmethylation in AIDS-associated myelopathy. Neurology 58(5):730–735
Ellaway C, Christodoulou J, Kamath R, Carpenter K, Wilcken B (1998) The association of protein-losing enteropathy with cobalamin C defect. J Inherit Metab Dis 21(1):17–22
Fowler B, Leonard JV, Baumgartner MR (2008) Causes of and diagnostic approach to methylmalonic acidurias. J Inherit Metab Dis 31(3):350–360
Geraghty MT, Perlman EJ, Martin LS et al (1992) Cobalamin C defect associated with hemolytic-uremic syndrome. J Pediatr 120(6):934–937
Gerth C, Morel CF, Feigenbaum A, Levin AV (2008) Ocular phenotype in patients with methylmalonic aciduria and homocystinuria, cobalamin C type. J AAPOS 12(6):591–596
Gold R, Bogdahn U, Kappos L et al (1996) Hereditary defect of cobalamin metabolism (homocystinuria and methylmalonic aciduria) of juvenile onset. J Neurol Neurosurg Psychiatr 60(1):107–108
Greitz D (2004) The hydrodynamic hypothesis versus the bulk flow hypothesis. Neurosurg Rev 27(4):299–300
Hannibal L, Kim J, Brasch NE et al (2009) Processing of alkylcobalamins in mammalian cells: a role for the MMACHC (cbl-C) gene product. Mol Genet Metab 97(4):260–266
Heil SG, Hogeveen M, Kluijtmans LAJ, van Dijken PJ, van de Berg GB, Blom HJ, Morava E (2007) Marfanoid features in a child with combined methylmalonic aciduria and homocystinuria (CblC type). J Inherit Metab Dis 30:811
Heinemann MK, Tomaske M, Trefz FK, Bosk A, Baden W, Ziemer G (2001) Ventricular septal defect closure in a neonate with combined methylmalonic aciduria/homocystinuria. Ann Thorac Surg 72(4):1391–1392
Huemer M, Simma B, Fowler B, Suormala T, Bodamer OA, Sass JO (2005) Prenatal and postnatal treatment in cobalamin C defect. J Pediatr 147(4):469–472
Kim J, Gherasim C, Banerjee R (2008) Decyanation of vitamin B12 by a trafficking chaperone. Proc Natl Acad Sci USA 105(38):14551–14554
Kim J, Hannibal L, Gherasim C, Jacobsen DW, Banerjee R (2009) A human vitamin B12 trafficking protein uses glutathione transferase activity for processing alkylcobalamins. J Biol Chem 284(48):33418–33424
Kölker S, Sauer SW, Hoffmann GF, Müller I, Morath MA, Okun JG (2008) Pathogenesis of CNS involvement in disorders of amino and organic acid metabolism. J Inherit Metab Dis 31:194–204
Kruman II, Culmsee C, Chan SL et al (2000) Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci 20(18):6920–6926
Kruman II, Kumaravel TS, Lohani A et al (2002) Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer’s disease. J Neurosci 22(5):1752–1762
Lerner-Ellis JP, Tirone JC, Pawelek PD et al (2006) Identification of the gene responsible for methylmalonic aciduria and homocystinuria, Cbl-C type. Nat Genet 38(1):93–100
Licastro F, Marocchi A, Penco S et al (2006) Does Down’s syndrome support the homocysteine theory of atherogenesis? Experience in elderly subjects with trisomy 21. Arch Gerontol Geriatr 43(3):381–387
Lin HJ, Neidich JA, Salazar D et al (2009) Asymptomatic maternal combined homocystinuria and methylmalonic aciduria (Cbl-C) detected through low carnitine levels on newborn screening. J Pediatr 155(6):924–927
Longo D, Fariello G, Dionisi-Vici C et al (2005) MRI and 1H-MRS findings in early-onset cobalamin C/D defect. Neuropediatrics 36(6):366–372
Maamar M, Mezalek ZT, Harmouche H, Adnaoui M, Aouni M, Maaouni A (2008) Contribution of spinal MRI for unsuspected cobalamin deficiency in isolated sub-acute combined degeneration. Eur J Intern Med 19(2):143–145
Martì-Carvajal AJ, Solà I, Lathyris D, Salanti G (2009) Homocysteine lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev. 7(4):CD006612
Mattson MP, Shea TB (2003) Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 26(3):137–146
McCaddon A, Kelly CL (1992) Alzheimer’s disease: a ‘cobalaminergic’ hypothesis. Med Hypotheses 37(3):161–165
McCully KS (1992) Homocystinuria, arteriosclerosis, methylmalonic aciduria, and methyltransferase deficiency: a key case revisited. Nutr Rev 50(1):7–12
Mitchell GA, Watkins D, Melançon SB et al (1986) Clinical heterogeneity in cobalamin C variant of combined homocystinuria and methylmalonic aciduria. J Pediatr 108(3):410–415
Morel CF, Lerner-Ellis JP, Rosenblatt DS (2006) Combined methylmalonic aciduria and homocystinuria (Cbl-C): phenotype-genotype correlations and ethnic-specific observations. Mol Genet Metab 88(4):315–321
Mudd SH, Skovby F, Levy HL et al (1985) The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet 37(1):1–31
Nogueira C, Aiello C, Cerone R et al (2008) Spectrum of MMACHC mutations in Italian and Portuguese patients with combined methylmalonic aciduria and homocystinuria, Cbl-C type. Mol Genet Metab 93(4):475–480
Nowak-Göttl U, Duering C, Kempf-Bielack B, Sträter R (2003) Thromboembolic diseases in neonates and children. Pathophysiol Haemost Thromb 33(5–6):269–274
Obeid R, Herrmann W (2006) Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett 580(13):2994–3005
Ogier de Baulny H, Gérard M, Saudubray JM, Zittoun J (1998) Remethylation defects: guidelines for clinical diagnosis and treatment. Eur J Pediatr 157(Suppl 2):S77–S83
Outinen PA, Sood SK, Pfeifer SI et al (1999) Homocysteine-induced endoplasmic reticulum stress and growth arrest leads to specific changes in gene expression in human vascular endothelial cells. Blood 94(3):959–967
Papatheodorou L, Weiss N (2007) Vascular oxidant stress and inflammation in hyperhomocysteinemia. Antioxid Redox Signal 9(11):1941–1945
Patton N, Beatty S, Lloyd IC, Wraith JE (2000) Optic atrophy in association with cobalamin C (Cbl-C) disease. Ophthalmic Genet 21(3):151–154
Pogribna M, Melnyk S, Pogribny I, Chango A, Yi P, James SJ (2001) Homocysteine metabolism in children with Down syndrome: in vitro modulation. Am J Hum Genet 69(1):88–95
Powers JM, Rosenblatt DS, Schmidt RE et al (2001) Neurological and neuropathologic heterogeneity in two brothers with cobalamin C deficiency. Ann Neurol 49(3):396–400
Profitlich LE, Kirmse B, Wasserstein MP, Diaz GA, Srivastava S (2009) High prevalence of structural heart disease in children with Cbl-C-type methylmalonic aciduria and homocystinuria. Mol Genet Metab 98(4):344–348
Regland B, Gottfries CG (1992) Slowed synthesis of DNA and methionine is a pathogenetic mechanism common to dementia in Down’s syndrome, AIDS and Alzheimer’s disease? Med Hypotheses 38(1):11–19
Regland B, Abrahamsson L, Blennow K, Gottfries CG, Wallin A (1992) Vitamin B12 in CSF: reduced CSF/serum B12 ratio in demented men. Acta Neurol Scand 85(4):276–281
Ricci D, Pane M, Deodato F et al (2005) Assessment of visual function in children with methylmalonic aciduria and homocystinuria. Neuropediatrics 36(3):181–185
Robb RM, Dowton SB, Fulton AB, Levy HL (1984) Retinal degeneration in vitamin B12 disorder associated with methylmalonic aciduria and sulfur amino acid abnormalities. Am J Ophthalmol 97(6):691–696
Robertson KD (2002) DNA methylation and chromatin. Unraveling the tangled web. Oncogene 21(35):5361–5379
Rosenblatt DS, Aspler AL, Shevell MI, Pletcher BA, Fenton WA, Seashore MR (1997) Clinical heterogeneity and prognosis in combined methylmalonic aciduria and homocystinuria (Cbl-C). J Inherit Metab Dis 20(4):528–538
Rossi A, Biancheri R, Tortori-Donati P (2001) The pathogenesis of hydrocephalus in inborn errors of the single carbon transfer pathway. Neuropediatrics 32(6):335–336
Roze E, Gervais D, Demeret S et al (2003) Neuropsychiatric disturbances in presumed late-onset cobalamin C disease. Arch Neurol 60(10):1457–1462
Russo P, Doyon J, Sonsino E, Ogier H, Saudubray JM (1992) A congenital anomaly of vitamin B12 metabolism: a study of three cases. Hum Pathol 23(5):504–512
Sauer SW, Opp S, Haarmann A, Okun JG, Kölker S, Morath MA (2009) Long-term exposure of human proximal tubule cells to hydroxycobalamin[c-lactam] as a possible model to study renal disease in methylmalonic acidurias. J Inherit Metab Dis 32(6):720–727, Epub 2009 Oct 10
Scalabrino G, Veber D, Mutti E (2007) New pathogenesis of the cobalamin-deficient neuropathy. Med Secoli 19(1):9–18
Schimel AM, Mets MB (2006) The natural history of retinal degeneration in association with cobalamin C (cbl C) disease. Ophthalmic Genet 27(1):9–14
Scott JM, Dinn JJ, Wilson P, Weir DG (1981) Pathogenesis of subacute combined degeneration: a result of methyl group deficiency. Lancet 2(8242):334–337
Selzer RR, Rosenblatt DS, Laxova R, Hogan K (2003) Adverse effect of nitrous oxide in a child with 5, 10-methylenetetrahydrofolate reductase deficiency. N Engl J Med 349(1):45–50
Sharma AP, Greenberg CR, Prasad AN, Prasad C (2007) Hemolytic uremic syndrome (HUS) secondary to cobalamin C (Cbl-C) disorder. Pediatr Nephrol 22(12):2097–2103
Shinnar S, Singer HS (1984) Cobalamin C mutation (methylmalonic aciduria and homocystinuria) in adolescence. A treatable cause of dementia and myelopathy. N Engl J Med 311(7):451–454
Smith AD (2008) The worldwide challenge of the dementias: a role for B vitamins and homocysteine? Food Nutr Bull 29(Suppl 2):S143–S172
Smith KL, Greenwood CE (2008) Weight loss and nutritional considerations in Alzheimer disease. J Nutr Elder 27(3–4):381–403
Smith SE, Kinney HC, Swoboda KJ, Levy HL (2006) Subacute combined degeneration of the spinal cord in Cbl-C disorder despite treatment with B12. Mol Genet Metab 88(2):138–145
Surtees R, Leonard J, Austin S (1991) Association of demyelination with deficiency of cerebrospinal-fluid S-adenosylmethionine in inborn errors of methyl-transfer pathway. Lancet 338(8782–8783):1550–1554
Tchantchou F, Graves M, Ortiz D, Chan A, Rogers E, Shea TB (2006) S-adenosyl methionine: a connection between nutritional and genetic risk factors for neurodegeneration in Alzheimer’s disease. J Nutr Health Aging 10(6):541–544
Thauvin-Robinet C, Roze E, Couvreur G et al (2008) The adolescent and adult form of cobalamin C disease: clinical and molecular spectrum. J Neurol Neurosurg Psychiatry 79(6):725–728, Epub 2008 Feb 1
Tomaske M, Bosk A, Heinemann MK et al (2001) Cbl-C/D defect combined with haemodynamically highly relevant VSD. J Inherit Metab Dis 24(4):511–512
Traboulsi EI, Silva JC, Geraghty MT, Maumenee IH, Valle D, Green WR (1992) Ocular histopathologic characteristics of cobalamin C type vitamin B12 defect with methylmalonic aciduria and homocystinuria. Am J Ophthalmol 113(3):269–280
Tsai AC, Morel CF, Scharer G et al (2007) Late-onset combined homocystinuria and methylmalonic aciduria (Cbl-C) and neuropsychiatric disturbance. Am J Med Genet A 143A(20):2430–2434
Tsina EK, Marsden DL, Hansen RM, Fulton AB (2005) Maculopathy and retinal degeneration in cobalamin C methylmalonic aciduria and homocystinuria. Arch Ophthalmol 123(8):1143–1146
Van Hove JL, Van Damme-Lombaerts R, Grünewald S et al (2002) Am J Med Genet 111(2):195–201
Vidal-Alaball J, Butler CC, Cannings-John R, et al (2005) Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev 20(3):CD004655
Wang G, Siow YL, K O (2000) Homocysteine stimulates nuclear factor kappaB activity and monocyte chemoattractant protein-1 expression in vascular smooth-muscle cells: a possible role for protein kinase C. Biochem J 352(Pt 3):817–826
Weisfeld-Adams JD, Morrissey MA, Kirmse BM et al (2010) Newborn screening and early biochemical follow-up in combined methylmalonic aciduria and homocystinuria, Cbl-C type, and utility of methionine as a secondary screening analyte. Mol Genet Metab 99(2):116–123
Weiss N (2005) Mechanisms of increased vascular oxidant stress in hyperhomocysteinemia and its impact on endothelial function. Curr Drug Metab 6(1):27–36
Welch GN, Loscalzo J (1998) Homocysteine and atherothrombosis. N Engl J Med 338(15):1042–1050
Wong A, Mok V, Fan YH, Lam WW, Liang KS, Wong KS (2006) Hyperhomocysteinemia is associated with volumetric white matter change in patients with small vessel disease. J Neurol 253(4):441–447
Wu S, Gonzalez-Gomez I, Coates T, Yano S (2005) Cobalamin C disease presenting with hemophagocytic lymphohistiocytosis. Pediatr Hematol Oncol 22(8):717–721
Yasui K, Kowa H, Nakaso K, Takeshima T, Nakashima K (2000) Plasma homocysteine and MTHFR C677T genotype in levodopa-treated patients with PD. Neurology 55(3):437–440
Younessi D, Moseley K, Yano S (2009) Creatine metabolism in combined methylmalonic aciduria and homocystinuria disease revisited. Ann Neurol 65(4):481–482
Zou CG, Banerjee R (2005) Homocysteine and redox signaling. Antioxid Redox Signal 7(5–6):547–559
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by: Brian Fowler
References to electronic databases: Methylmalonic aciduria and homocystinuria cbl-C type: OMIM #277400
MMACHC gene: OMIM *609831
Competing interest: None declared.
Rights and permissions
About this article
Cite this article
Martinelli, D., Deodato, F. & Dionisi-Vici, C. Cobalamin C defect: natural history, pathophysiology, and treatment. J Inherit Metab Dis 34, 127–135 (2011). https://doi.org/10.1007/s10545-010-9161-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-010-9161-z